Request Demo
Last update 27 Feb 2026
AC group meningococcal Haemophilus influenzae type b (combined) vaccine(Chengdu Olymvax Biopharmaceuticals)
Last update 27 Feb 2026
Overview
Basic Info
Drug Type Combination vaccine, Prophylactic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with AC group meningococcal Haemophilus influenzae type b (combined) vaccine(Chengdu Olymvax Biopharmaceuticals)CTR20191736
评价A群C群脑膜炎球菌-b型流感嗜血杆菌（结合）联合疫苗安全性与免疫原性的随机、盲法、对照的Ⅲ期临床试验
[Translation] A randomized, blinded, controlled phase III clinical trial to evaluate the safety and immunogenicity of group A and group C meningococcal-Haemophilus influenzae type b combined vaccine
CTR20190550
评价A群C群脑膜炎球菌-b型流感嗜血杆菌（结合）联合疫苗安全 性的Ⅰ期临床试验
[Translation] Phase I clinical trial to evaluate the safety of group A and group C meningococcal-Haemophilus influenzae type b combined vaccine
100 Clinical Results associated with AC group meningococcal Haemophilus influenzae type b (combined) vaccine(Chengdu Olymvax Biopharmaceuticals)
Login to view more data
100 Translational Medicine associated with AC group meningococcal Haemophilus influenzae type b (combined) vaccine(Chengdu Olymvax Biopharmaceuticals)
Login to view more data
100 Patents (Medical) associated with AC group meningococcal Haemophilus influenzae type b (combined) vaccine(Chengdu Olymvax Biopharmaceuticals)
Login to view more data
100 Deals associated with AC group meningococcal Haemophilus influenzae type b (combined) vaccine(Chengdu Olymvax Biopharmaceuticals)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilus influenza infection | NDA/BLA | China | 14 Feb 2023 | |
| Meningococcal Infections | NDA/BLA | China | 14 Feb 2023 | |
| Arthritis | Phase 3 | China | 06 Oct 2019 | |
| Cellulitis | Phase 3 | China | 06 Oct 2019 | |
| Epiglottitis | Phase 3 | China | 06 Oct 2019 | |
| Meningitis, Meningococcal | Phase 3 | China | 06 Oct 2019 | |
| Pneumonia | Phase 3 | China | 06 Oct 2019 | |
| Sepsis | Phase 3 | China | 06 Oct 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free